Antegrin Therapeutics
About:
Antegrin Therapeutics is a Biotechnology company located in 4320 Forest Park Ave., Ste. 304, St. Louis, MO, United States.
Top Investors: BioGenerator, Missouri Technology Corporation, iSelect Fund
Description:
Antegrin Therapeutics, LLC, is a drug discovery and development company focused on the development of novel therapies for fibrotic diseases. Our lead program aims to develop a treatment for idiopathic pulmonary fibrosis, a progressive, life-threatening condition that currently has no FDA-approved medication.
Total Funding Amount:
$800000
Headquarters Location:
St Louis, Missouri, United States
Founded Date:
2012-01-01
Founders:
David Griggs, Peter Ruminski, Robert Karr
Number of Employees:
1-10
Last Funding Date:
2015-10-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai